Differentiation between malignant and benign pathologic fractures with F-18-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography

Skeletal Radiology

Volumn 37, Issue 5, 2008, Pages 415-421

  Shin, D S ^a   Shon, O J ^a   Byun, S J ^a   Choi, J H ^a   Chun, K A ^a   Cho, I H ^a  

^a Yeungnam University College of Medicine   (South Korea)

Author keywords

F 18 FDG PET CT; Molecular imaging; Neoplasm; Pathologic fracture

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE CANCER; BONE MARROW; BONE METASTASIS; BONE TUMOR; CANCER DIAGNOSIS; CANCER PATIENT; CHILD; CHONDROSARCOMA; CLINICAL ARTICLE; CLINICAL EXAMINATION; CORTICAL BONE; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; DRUG UPTAKE; FEMALE; FOLLOW UP; HUMAN; MALE; MOLECULAR IMAGING; PATHOLOGIC FRACTURE; PELVIS FRACTURE; PRIORITY JOURNAL; RADIODIAGNOSIS; RIB FRACTURE; SOFT TISSUE; SPINE FRACTURE; SQUAMOUS CELL CARCINOMA; STANDARD; WHOLE BODY CT; WHOLE BODY PET;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE NEOPLASMS; CHILD; COHORT STUDIES; FEMALE; FLUORODEOXYGLUCOSE F18; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 43349090796     PISSN: 03642348     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00256-008-0462-3     Document Type: Article

References (17)

1. Gambhir SS. Molecular imaging of cancer with positron emission tomography. Nat Rev Cancer 2002; 2(9): 683-693.
2. Schwarzbach MH, Dimitrakopoulou-Strauss A, Willeke F, et al. Clinical value of [18-F] fluorodeoxyglucose positron emission tomography imaging in soft tissue sarcomas. Ann Surg 2000; 231(3): 380-386.
3. Wu H, Dimitrakopoulou-Strauss A, Heichel TO, et al. Quantitative evaluation of skeletal tumours with dynamic FDG PET: SUVmax in comparison to Patlak analysis. Eur J Nucl Med 2001; 28(6): 704-710.
4. Taira AV, Herfkens RJ, Gambhir SS, Quon A. Detection of bone metastases: assessment of integrated FDG PET/CT imaging. Radiology 2007; 243(1): 204-211.
5. Loft A, Berthelsen AK, Roed H, et al. The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. Gynecol Oncol 2007; 106(1): 29-34.
6. Iagaru A, Quon A, McDougall IR, Gambhir SS. F-18 FDG PET/CT evaluation of osseous and soft tissue sarcomas. Clin Nucl Med 2006; 31(12): 754-760.
7. McCarville MB, Christie R, Daw NC, Spunt SL, Kaste SC. PET/CT in the evaluation of childhood sarcomas. AJR Am J Roentgenol 2005; 184(4): 1293-1304.
8. Paul R, Ahonen A, Virtama P, Aho A, Ekfors T. F-18 fluorodeoxyglucose: its potential in differentiating between stress fracture and neoplasia. Clin Nucl Med 1989; 14(12): 906-908.
9. Schmitz A, Risse JH, Textor J, et al. FDG-PET Findings of vertebral compression fractures in osteoporosis: preliminary results. Osteoporos Int 2002; 13(9): 755-761.
10. Shon IH, Fogelman I. F-18 FDG positron emission tomography and benign fractures. Clin Nucl Med 2003; 28(3): 171-175.
11. Kato K, Aoki J, Endo K. Utility of FDG-PET in differential diagnosis of benign and malignant fractures in acute to subacute phase. Ann Nucl Med 2003; 17(1): 41-46.
12. Katzel JA, Heiba SI. PET/CT F-18 FDG scan accurately identifies osteoporotic fractures in a patient with known metastatic colorectal cancer. Clin Nucl Med 2005; 30(10): 651-654.
13. Tsuchida T, Kosaka N, Sugimoto K, Itoh H. Sacral insufficiency fracture detected by FDG-PET/CT: report of 2 cases. Ann Nucl Med 2006; 20(6): 445-448.
14. Aoki J, Watanabe H, Shinozaki T, et al. FDG PET of primary benign and malignant bone tumors: standardized uptake value in 52 lesions. Radiology 2001; 219(3): 774-777.
15. Meyer M, Gast T, Raja S, Hubner K. Increased F-18 FDG accumulation in an acute fracture. Clin Nucl Med 1994; 19(1): 13-14.
16. Ravenel JG, Gordon LL, Pope TL, Reed CE. FDG-PET uptake in occult acute pelvic fracture. Skeletal Radiol 2004; 33(2): 99-101.
17. Zhuang H, Sam JW, Chacko TK, et al. Rapid normalization of osseous FDG uptake following traumatic or surgical fractures. Eur J Nucl Med Mol Imaging 2003; 30(8): 1096-1103.